cTAPcTAPcTAPcTAP
  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

The Problem with Clinical Trials in Duchenne—and What We Can Do About It

Home / Blog / News & Press / The Problem with Clinical Trials in Duchenne—and What We Can Do About It

2021 WMS Late Breaking Poster – Genotype Study
Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls

The Problem with Clinical Trials in Duchenne—and What We Can Do About It

cTAP founders Susan J. Ward and James Signorovitch have written an article featured in Genetic Engineering & Biotechnology News: The Problem with Clinical Trials in Duchenne—and What We Can Do About It.

View the Full Article

16
Nov 2021
By SCsbox3AdminNews & PressComments Off on The Problem with Clinical Trials in Duchenne—and What We Can Do About It

Read the latest

  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation
  • A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy
  • Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study
  • Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials
  • New study may help more DMD patients be included in clinical trials

COLLABORATIVE TRAJECTORY
ANALYSIS PROJECT

501 (c) 3 nonprofit organization

Cambridge Innovative Center
One Broadway, Cambridge, MA 02142

T: 617-555-5555
E: info@ctap-nmd.org

Terms & Conditions
Privacy Policy

© 2026 Collaborative Trajectory Analysis Project. All rights reserved.

  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

Terms and Conditions - Privacy Policy